Published TCIMAIL newest issue No.197
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 790299-79-5 | Product Number: M3487
Masitinib
×
![]()
×
Purity: >95.0%(T)(HPLC)
Synonyms:
- N-[4-Methyl-3-[[4-(pyridin-3-yl)thiazol-2-yl]amino]phenyl]-4-[(4-methylpiperazin-1-yl)methyl]benzamide
- 4-[(4-Methyl-1-piperazinyl)methyl]-N-(4-methyl-3-{[4-(3-pyridinyl)-1,3-thiazol-2-yl]amino}phenyl)benzamide
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 100MG |
€270.00
|
Contact Us | 6 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | M3487 |
| Purity / Analysis Method | >95.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__2__8H__3__0N__6OS = 498.65 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Refrigerated (0-10°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive,Heat Sensitive |
| CAS RN | 790299-79-5 |
| Reaxys Registry Number | 12083382 |
| MDL Number | MFCD09954132 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 95.0 area% |
| Purity(Nonaqueous Titration) | min. 95.0 % |
| NMR | confirm to structure |
Properties (reference)
GHS
Related Laws:
Transport Information:
Application
Masitinib: A Potent and Selective Inhibitor of the Receptor Tyrosine Kinase c-Kit.
The stem cell factor (SCF) receptor, c-kit receptor, is a member of the type III receptor protein tyrosine kinase (RTK) family. Masitinib (AB1010) is a potent and selective inhibitor of the receptor tyrosine kinase c-Kit.1.2) It is also an inhibitor of platelet-derived growth factor receptor alpha/beta (PDGFR α/ß), lymphocyte-specific kinase (Lck), Lck/Yes-related protein (LYn), fibroblast growth factor receptor 3 (FGFR3) and focal adhesion kinase (FAK).2) Masitinib was originally developed for the treatment of cancer, mastocytosis and inflammatory diseases as a molecularly targeted drug. Recently, masitinib has also attracted attention as a treatment for neurodegenerative diseases such as Alzheimer's disease (AD) and Amyotrophic Lateral Sclerosis (ALS).3,4) (The product is for research use only.)
References
- 1) Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT
- 2) Masitinib (AB1010), from canine tumor model to human clinical development: Where we are? (a review)
- 3) Masitinib for the Treatment of Alzheimer’s disease (a review)
- 4) Masitinib: The promising actor in the next season of the Amyotrophic Lateral Sclerosis treatment series
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.